Top

BMC Psychiatry

Published in:

Open Access 01-12-2019 | Affective Disorder | Research article

A test of the goodness of fit of the generic metacognitive model of psychopathology symptoms

Authors: Henrik Nordahl, Ingunn Harsvik Ødegaard, Odin Hjemdal, Adrian Wells

Published in: BMC Psychiatry | Issue 1/2019

Abstract

Background

Common mental disorders such as depression and anxiety frequently co-occur and may share etiological mechanisms. The metacognitive model is based on the principle that there are common pathological mechanisms across disorders that account for comorbidity and therefore can be conceptualized in one generic model. A central prediction of the model is that particular metacognitive beliefs concerning the value of worry, and the uncontrollability and danger of cognition are positively correlated with psychopathology symptoms. In the present study, we set out to test the overall fit of this model by assessing generic metacognitive beliefs and judgements of attention control capacity as predictors of common and frequently co-occurring emotional distress symptoms.

Methods

In a cross-sectional design, 645 participants gathered at convenience completed a battery of self-report questionnaires.

Results

Structural equation modelling indicated a good model fit for the generic metacognitive model, and the predictors accounted for 93% of the variance in distress consisting of depression-, generalized- and social anxiety symptoms.

Conclusions

This finding supports the generic model and the implication that it can be used as a basis to formulate and treat multiple presenting problems.

National Institute for Health and Care Excellence: Depression in adults: recognition and management. (Clinical guideline 90). https://www.nice.org.uk/guidance/cg90 (2009). Accessed 20 Nov 2018.

National Institute for Health and Care Excellence: Generalized anxiety disorder and panic disorder in adults: management. (Clinical guideline 113). http://guidance.nice.org.uk/CG113 (2011). Accessed 20 Nov 2018.

National Institute for Health and Care Excellence. Social anxiety disorder: recognition, assessment and treatment of social anxiety disorder. (Clinical guideline 159). http://guidance.nice.org.uk/CG159 (2013). Accessed 20 Nov 2018.

Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess. 2009;21:256–71 https://doi.org/10.1037/a0016608.CrossRefPubMedPubMedCentral

Wells A, Matthews G. Attention and emotion: a clinical perspective. Hove: Erlbaum; 1994.

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27. https://doi.org/10.1001/archpsyc.62.6.617.CrossRefPubMedPubMedCentral

Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JA, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;doi:https://doi.org/10.1002/da.22728.CrossRefPubMedPubMedCentral

Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatr. 2013;58:376–85 https://doi.org/10.1177/070674371305800702.CrossRef

Springer KS, Levy HC, Tolin DF. Remission in CBT for adult anxiety disorders: a meta-analysis. Clin Psychol Rev. 2018;61:1–8 https://doi.org/10.1016/j.cpr.2018.03.002.CrossRefPubMed

10.

Naragon-Gainey K, Watson D. What lies beyond neuroticism? An examination of the unique contributions of social-cognitive vulnerabilities to internalizing disorders. Assessment. 2018;25:143–58 https://doi.org/10.1177/1073191116659741.CrossRefPubMed

11.

Caspi A, Houts RM, Belsky DW, Goldman-Mellor SJ, Harrington H, Israel S, et al. The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci. 2014;2:119–37 https://doi.org/10.1177/2167702613497473.CrossRefPubMedPubMedCentral

12.

Rosenström T, Gjerde LC, Krueger RF, Aggen SH, Czajkowski NO, Gillespie NA, et al. Joint factorial structure of psychopathology and personality. Psychol Med. 2018:1–10 https://doi.org/10.1017/S0033291718002982.CrossRefPubMed

13.

Wells A, Matthews G. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther. 1996;34:881–8. https://doi.org/10.1016/S0005-7967(96)00050-2.CrossRefPubMed

14.

Wells A. Metacognitive therapy for anxiety and depression. New York: Guilford press; 2009.

15.

Ohayon MM, Schatzberg AF. Social phobia and depression: prevalence and comorbidity. J Psychosom Res. 2010;68:235–43 https://doi.org/10.1016/j.jpsychores.2009.07.018.CrossRefPubMed

16.

Wittchen HU. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety. 2002;16:162–71 https://doi.org/10.1002/da.10065.CrossRefPubMed

17.

World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization. Licence: CC BY-NCSA 3.0 IGO; 2017.

18.

Wells A, Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther. 2004;42:385–96. https://doi.org/10.1016/S0005-7967(03)00147-5.CrossRefPubMed

19.

Sun X, Zhu C, So SHW. Dysfunctional metacognition across psychopathologies: a meta-analytic review. Eur Psychiatry. 2017;45:139–53 https://doi.org/10.1016/j.eurpsy.2017.05.029.CrossRefPubMed

20.

Gkika S, Wittkowski A, Wells A. Social cognition and metacognition in social anxiety: a systematic review. Clin Psychol Psychother. 2017;25:10–30. https://doi.org/10.1002/cpp.2127.CrossRefPubMed

21.

Nordahl H, Nordahl HM, Hjemdal O, Wells A. Cognitive and metacognitive predictors of symptom improvement following treatment of social anxiety disorder: a secondary analysis from a randomized controlled trial. Clin Psychol Psychother. 2017:1–7. https://doi.org/10.1002/cpp.2083.CrossRef

22.

Nordahl H, Hjemdal O, Hagen R, Nordahl HM, Wells A. What lies beneath trait-anxiety? Testing the Self-Regulatory Executive Function Model of Vulnerability. Front Psychol. 2019;10:122. https://doi.org/10.3389/fpsyg.2019.00122.CrossRefPubMedPubMedCentral

23.

Papageorgiou C, Wells A. A prospective test of the clinical metacognitive model of rumination and depression. Int J Cogn Ther. 2009;2:123–31 https://doi.org/10.1521/ijct.2009.2.2.123.CrossRef

24.

Ryum T, Kennair LEO, Hjemdal O, Hagen R, Halvorsen JØ, Solem S. Worry and metacognitions as predictors of anxiety symptoms: a prospective study. Front Psychol. 2017;8:924 https://doi.org/10.3389/fpsyg.2017.00924.CrossRefPubMedPubMedCentral

25.

Derryberry D, Reed MA. Anxiety-related attentional biases and their regulation by attentional control. J Abnorm Psychol. 2002;111:225–36 https://doi.org/10.1037/0021-843X.111.2.225.CrossRefPubMed

26.

Quigley L, Wright CA, Dobson KS, Sears CR. Measuring attentional control ability or beliefs? Evaluation of the factor structure and convergent validity of the attentional control scale. J Psychopathol Behav Assess. 2017;39:742–54 https://doi.org/10.1007/s10862-017-9617-7.CrossRef

27.

Williams PG, Rau HK, Suchy Y, Thorgusen SR, Smith TW. On the validity of self-report assessment of cognitive abilities: attentional control scale associations with cognitive performance, emotional adjustment, and personality. Psychol Assess. 2017;29:519–30 https://doi.org/10.1037/pas0000361.CrossRefPubMed

28.

Reinholdt-Dunne ML, Mogg K, Bradley BP. Attention control: relationships between self-report and behavioural measures, and symptoms of anxiety and depression. Cogn Emot. 2013;27:430–40 https://doi.org/10.1080/02699931.2012.715081.CrossRefPubMed

29.

Hsu KJ, Beard C, Rifkin L, Dillon DG, Pizzagalli DA, Björgvinsson T. Transdiagnostic mechanisms in depression and anxiety: the role of rumination and attentional control. J Affect Disord. 2015;188:22–7 https://doi.org/10.1016/j.jad.2015.08.008.CrossRefPubMedPubMedCentral

30.

Armstrong T, Zald DH, Olatunji BO. Attentional control in OCD and GAD: specificity and associations with core cognitive symptoms. Behav Res Ther. 2011;49:756–62 https://doi.org/10.1016/j.brat.2011.08.003.CrossRefPubMedPubMedCentral

31.

Sluis RA, Boschen MJ, Neumann DL, Murphy K. Attentional control associated with core cognitive maintenance factors of social anxiety. J Exp Psychopathol. 2018; https://doi.org/10.1177/2043808718798076.CrossRef

32.

O’Carroll PJ, Fisher P. Metacognitions, worry and attentional control in predicting OSCE performance test anxiety. Med Educ. 2013;47:562–8. https://doi.org/10.1111/medu.12125.CrossRefPubMed

33.

Spada MM, Georgiou GA, Wells A. The relationship among metacognitions, attentional control, and state anxiety. Cogn Behav Ther. 2010;39:64–71 https://doi.org/10.1080/16506070902991791.CrossRefPubMed

34.

Fernie BA, McKenzie AM, Nikčević AV, Caselli G, Spada MM. The contribution of metacognitions and attentional control to decisional procrastination. J Ration Emot Cogn Behav Ther. 2016;34:1–13. https://doi.org/10.1007/s10942-015-0222-y.CrossRef

35.

Reinholdt-Dunne ML, Blicher A, Nordahl H, Normann N, Esbjørn BH, Wells A. Modeling the relationship between metacognitive beliefs, attentional control and symptoms in children with and without anxiety disorders: a test of the S-REF model. Front Psychol. 2019;10(1205). https://doi.org/10.3389/fpsyg.2019.01205.

36.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13 https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

37.

Kroenke K, Spitzer RL, Williams JB, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59 https://doi.org/10.1016/j.genhosppsych.2010.03.006.CrossRefPubMed

38.

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

39.

Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969;33:448–57. https://doi.org/10.1037/h002780.CrossRefPubMed

40.

Spada MM, Mohiyeddini C, Wells A. Measuring metacognitions associated with emotional distress: factor structure and predictive validity of the metacognitions questionnaire 30. Pers Individ Dif. 2008;45:238–42 https://doi.org/10.1016/j.paid.2008.04.005.CrossRef

41.

Ólafsson RP, Smári J, Guðmundsdóttir F, Ólafsdóttir G, Harðardóttir HL, Einarsson SM. Self reported attentional control with the attentional control scale: factor structure and relationship with symptoms of anxiety and depression. J Anxiety Disord. 2011;25:777–82. https://doi.org/10.1016/j.janxdis.2011.03.013.CrossRefPubMed

42.

Judah MR, Grant DM, Mills AC, Lechner WV. Factor structure and validation of the attentional control scale. Cogn Emot. 2014;28:433–51. https://doi.org/10.1080/02699931.2013.835254.CrossRefPubMed

43.

Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1–55 https://doi.org/10.1080/10705519909540118.CrossRef

44.

Kline RB. Principles and practice of structural equation modelling. 3rd ed. New York: Guilford; 2011.

45.

Cartwright-Hatton S, Wells A. Beliefs about worry and intrusions: the meta-cognitions questionnaire and its correlates. J Anxiety Disord. 1997;11:279–96. https://doi.org/10.1016/S0887-6185(97)00011-X.CrossRefPubMed

46.

Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. Multivariate data analysis. Seventh ed. Pearson new international: Harlow, Essex; 2014.

47.

Spada MM, Roarty A. The relative contribution of metacognitions and attentional control to the severity of gambling in problem gamblers. Addict Behav Rep. 2015;1:7–11 https://doi.org/10.1016/j.abrep.2015.02.001.CrossRefPubMedPubMedCentral

48.

Fergus TA, Bardeen JR, Orcutt HK. Attentional control moderates the relationship between activation of the cognitive attentional syndrome and symptoms of psychopathology. J Individ Differ. 2012;53:213–7 https://doi.org/10.1016/j.paid.2012.03.017.CrossRef

49.

Papageorgiou C, Wells A. An empirical test of a clinical metacognitive model of rumination and depression. Cognit Ther Res. 2003;27:261–73 https://doi.org/10.1023/A:1023962332399.CrossRef

50.

Nordahl H, Wells A. Testing the metacognitive model against the benchmark CBT model of social anxiety disorder: is it time to move beyond cognition? PLoS One. 2017;12:e0177109 https://doi.org/10.1371/journal.pone.0177109.CrossRefPubMedPubMedCentral

51.

Nordahl H, Nordahl HM, Vogel PA, Wells A. Explaining depression symptoms in patients with social anxiety disorder: do maladaptive metacognitive beliefs play a role? Clin Psychol Psychother. 2018;25:457–64 https://doi.org/10.1002/cpp.2181.CrossRefPubMed

52.

Hagen R, Hjemdal O, Solem S, Kennair LEO, Nordahl HM, Fisher P. Metacognitive therapy for depression in adults: a waiting list randomized controlled trial with six months follow-up. Front Psychol. 2017;8:31. https://doi.org/10.3389/fpsyg.2017.00031.CrossRefPubMedPubMedCentral

53.

Groves SJ, Porter RJ, Jordan J, Knight R, Carter JD, McIntosh VV, et al. Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depression. Depress Anxiety. 2015;32:437–44. https://doi.org/10.1002/da.22341.CrossRefPubMed

54.

Hjemdal O, Hagen R, Solem S, Nordahl H, Kennair LEO, Ryum T, et al. Metacognitive therapy in major depression: an open trial of comorbid cases. Cog Behav Pract. 2017;3:312–8 https://doi.org/10.1016/j.cbpra.2016.06.006.CrossRef

55.

Strand ER, Hagen R, Hjemdal O, Kennair LEO, Solem S. Metacognitive therapy for depression reduces interpersonal problems: results from a randomized controlled trial. Front Psychol. 2018;9:1415 https://doi.org/10.3389/fpsyg.2018.01415.CrossRefPubMedPubMedCentral

56.

Nordahl HM. Effectiveness of brief metacognitive therapy versus cognitive-behavioral therapy in a general outpatient setting. Int J Cogn Ther. 2009;2:152–9 https://doi.org/10.1521/ijct.2009.2.2.152.CrossRef

57.

Capobianco L, Reeves D, Morrison AP, Wells A. Group metacognitive therapy vs. mindfulness meditation therapy in a Transdiagnostic patient sample: a randomised feasibility trial. Psychiatry Res. 2018;259:554–61 https://doi.org/10.1016/j.psychres.2017.11.045.CrossRefPubMed

58.

Johnson SU, Hoffart A, Nordahl HM, Wampold B. Metacognitive therapy versus disorder-specific CBT for comorbid anxiety disorders: a randomized controlled trial. J Anxiety Disord. 2017;50:103–12 https://doi.org/10.1016/j.janxdis.2017.06.004.CrossRefPubMed

Title: A test of the goodness of fit of the generic metacognitive model of psychopathology symptoms
Authors: Henrik Nordahl
Ingunn Harsvik Ødegaard
Odin Hjemdal
Adrian Wells
Publication date: 01-12-2019
Publisher: BioMed Central
Keywords: Affective Disorder
Affective Disorder
Anxiety
Published in: BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-019-2266-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A test of the goodness of fit of the generic metacognitive model of psychopathology symptoms

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Hyperactivity/restlessness is associated with increased functional connectivity in adults with ADHD: a dimensional analysis of resting state fMRI

The quality and quantity of staff-patient interactions as recorded by staff. A registry study of nursing documentation in two inpatient mental health wards

Mediators of gender effects on depression among cardiovascular disease patients in Palestine

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental

Associations of personality traits with internet addiction in Chinese medical students: the mediating role of attention-deficit/hyperactivity disorder symptoms

HELP@APP: development and evaluation of a self-help app for traumatized Syrian refugees in Germany – a study protocol of a randomized controlled trial